|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.46 EUR | +2.25% |
|
-3.74% | +4.90% |
| 09/02 | Eurofins Viracor BioPharma Expands Bioanalytical Capabilities | CI |
| 30/01 | Eurofins, Winfarm, Worldline... Stocks to Watch Today in Paris - |  |
| Capitalization | 1.16TCr 1.37TCr 1.05TCr 1.01TCr 1.87TCr 1,24200Cr 1.94TCr 12TCr 4.87TCr 60TCr 5.14TCr 5.04TCr 2,09600Cr | P/E ratio 2025 |
28x | P/E ratio 2026 * | 21.3x |
|---|---|---|---|---|---|
| Enterprise value | 1.52TCr 1.8TCr 1.38TCr 1.32TCr 2.45TCr 1,62900Cr 2.55TCr 16TCr 6.38TCr 79TCr 6.75TCr 6.61TCr 2,75000Cr | EV / Sales 2025 |
1.51x | EV / Sales 2026 * | 1.93x |
| Free-Float |
66.44% | Yield 2025 * |
0.97% | Yield 2026 * | 1.14% |
Last Transcript: Eurofins Scientific SE
| 1 day | +2.25% | ||
| 1 week | -3.74% | ||
| Current month | -3.93% | ||
| 1 month | -10.48% | ||
| 3 months | +10.02% | ||
| 6 months | -2.01% | ||
| Current year | +4.90% |
| 1 week | 62.88 |  | 68.42 |
| 1 month | 62.88 | | 73.1 |
| Current year | 61.76 | | 74.32 |
| 1 year | 45.56 | | 74.32 |
| 3 years | 39.47 | | 74.32 |
| 5 years | 39.47 | | 127.68 |
| 10 years | 28.2 | | 127.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 01/01/1987 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 01/01/2015 |
Christian Wurst
PRN | Corporate Officer/Principal | 53 | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 01/01/1987 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 01/01/2015 |
Valérie Hanote
BRD | Director/Board Member | 60 | 01/01/1990 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -0.48% | 0.47% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.25% | -3.74% | +29.62% | -3.02% | 1.37TCr | |
| +4.62% | +0.73% | -12.88% | -4.40% | 4.76TCr | |
| -0.10% | -2.22% | +49.90% | +43.32% | 3.83TCr | |
| -0.21% | +8.18% | +39.13% | +61.33% | 3.61TCr | |
| -1.13% | -10.96% | -13.70% | -26.48% | 2.83TCr | |
| -1.05% | -1.21% | +136.81% | +277.83% | 1.86TCr | |
| +7.58% | +14.65% | +31,531.21% | +4,137.24% | 1.54TCr | |
| -0.82% | -2.62% | +50.14% | +94.88% | 1.33TCr | |
| -1.44% | -6.82% | +159.66% | +105.56% | 1.31TCr | |
| +2.88% | -21.03% | +25.83% | +97.13% | 1.21TCr | |
| Average | +1.26% | -2.97% | +3,199.57% | +478.34% | 2.37TCr | |
| Weighted average by Cap. | +1.31% | -1.95% | +2,092.83% | +320.12% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 732.35Cr 869.16Cr 667.97Cr 637.72Cr 1.18TCr 79TCr 1.23TCr 7.77TCr 3.08TCr 38TCr 3.26TCr 3.19TCr 1,32900Cr | 765.07Cr 907.99Cr 697.82Cr 666.21Cr 1.24TCr 82TCr 1.28TCr 8.12TCr 3.22TCr 40TCr 3.41TCr 3.34TCr 1,38800Cr |
| Net income | 47Cr 56Cr 43Cr 41Cr 76Cr 5.08TCr 79Cr 500.97Cr 198.88Cr 2.45TCr 210.18Cr 205.85Cr 8.57TCr | 57Cr 67Cr 52Cr 49Cr 92Cr 6.11TCr 95Cr 602.95Cr 239.36Cr 2.95TCr 252.96Cr 247.76Cr 10TCr |
| Net Debt | 360.2Cr 427.49Cr 328.54Cr 313.66Cr 582.23Cr 39TCr 604.94Cr 3.82TCr 1.52TCr 19TCr 1.6TCr 1.57TCr 65TCr | 323.98Cr 384.5Cr 295.5Cr 282.11Cr 523.68Cr 35TCr 544.1Cr 3.44TCr 1.36TCr 17TCr 1.44TCr 1.41TCr 59TCr |
Employees
65,000
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 65.46 € | +2.25% | 3,07,579 |
| 12/26/12 | 64.02 € | -1.05% | 4,68,015 |
| 11/26/11 | 64.70 € | -4.06% | 2,76,628 |
| 10/26/10 | 67.44 € | +0.33% | 2,86,010 |
| 09/26/09 | 67.22 € | -1.15% | 2,90,511 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
65.46EUR
Average target price
70.26EUR
Spread / Average Target
+7.33%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ERF Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition